Details of the Drug Reposition

General Information of This Drug (ID: DM3PJZH)

• Drug Name: JTCR016 (DM3PJZH)

Information on Drug Reposition of This Drug

2 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Chronic myelogenous leukaemia	DIS0301E	2A20.0	Phase 1/2	[1]
Acute myeloid leukaemia	DIS0BM1I	2A60	Phase 1/2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)